Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 142

1.
2.

Effects of Black Raspberries and Their Constituents on Rat Prostate Carcinogenesis and Human Prostate Cancer Cell Growth In Vitro.

Eskra JN, Dodge A, Schlicht MJ, Bosland MC.

Nutr Cancer. 2019 Aug 12:1-14. doi: 10.1080/01635581.2019.1650943. [Epub ahead of print]

PMID:
31402717
3.

Novel insight in estrogen homeostasis and bioactivity in the ACI rat model of estrogen-induced mammary gland carcinogenesis.

Pemp D, Esch HL, Hauptstein R, Möller FJ, Zierau O, Bosland MC, Geppert LN, Kleider C, Schlereth K, Vollmer G, Lehmann L.

Arch Toxicol. 2019 Jul;93(7):1979-1992. doi: 10.1007/s00204-019-02483-w. Epub 2019 May 22.

PMID:
31119341
4.

Role of Estrogen in Androgen-Induced Prostate Carcinogenesis in NBL Rats.

Ozten N, Vega K, Liehr J, Huang X, Horton L, Cavalieri EL, Rogan EG, Bosland MC.

Horm Cancer. 2019 Jun;10(2-3):77-88. doi: 10.1007/s12672-019-00360-7. Epub 2019 Mar 16.

PMID:
30877616
5.
6.

Global health and cancer.

Bosland MC.

Lancet. 2019 Mar 9;393(10175):983. doi: 10.1016/S0140-6736(18)33068-X. No abstract available.

PMID:
30860046
7.

How accurately do routinely reported HIV viral load suppression proportions reflect progress towards the 90-90-90 target in the population on antiretroviral treatment in Khayelitsha, South Africa?

Euvrard J, Schulz T, Hilderbrand K, Bosland M, Osler M, Boulle A, Davies MA.

S Afr Med J. 2019 Feb 26;109(3):174-177. doi: 10.7196/SAMJ.2019.v109i3.13456.

8.

Victor Feron, A life dedicated to toxicology and toxicologic pathology.

Kuper CF, Bosland MC.

Food Chem Toxicol. 2019 Mar;125:438. doi: 10.1016/j.fct.2019.01.006. Epub 2019 Jan 29. No abstract available.

PMID:
30707904
9.

Evaluation of Bisphenol A (BPA) Exposures on Prostate Stem Cell Homeostasis and Prostate Cancer Risk in the NCTR-Sprague-Dawley Rat: An NIEHS/FDA CLARITY-BPA Consortium Study.

Prins GS, Hu WY, Xie L, Shi GB, Hu DP, Birch L, Bosland MC.

Environ Health Perspect. 2018 Nov;126(11):117001. doi: 10.1289/EHP3953.

10.

Identification of a Subtype of Poorly Differentiated Invasive Ductal Carcinoma of the Breast Based on Vimentin and E-cadherin Expression.

Orlandini LF, Reis FJCD, da Silveira WA, Tiezzi MG, de Andrade JM, Ribeiro-Silva A, Deaton R, Bosland M, Tiezzi DG.

Rev Bras Ginecol Obstet. 2018 Dec;40(12):779-786. doi: 10.1055/s-0038-1673700. Epub 2018 Oct 25.

11.

Lack of combination effects of soy isoflavones and taxane chemotherapy of castration-resistant prostate cancer.

Eskra JN, Schlicht MJ, Bosland MC.

Prostate. 2019 Feb;79(2):223-233. doi: 10.1002/pros.23727. Epub 2018 Oct 21.

PMID:
30345530
12.

Long-Term Improvement of Neurological Signs and Metabolic Dysfunction in a Mouse Model of Krabbe's Disease after Global Gene Therapy.

Marshall MS, Issa Y, Jakubauskas B, Stoskute M, Elackattu V, Marshall JN, Bogue W, Nguyen D, Hauck Z, Rue E, Karumuthil-Melethil S, Zaric V, Bosland M, van Breemen RB, Givogri MI, Gray SJ, Crocker SJ, Bongarzone ER.

Mol Ther. 2018 Mar 7;26(3):874-889. doi: 10.1016/j.ymthe.2018.01.009. Epub 2018 Jan 17.

13.

Vitamin K2, a menaquinone present in dairy products targets castration-resistant prostate cancer cell-line by activating apoptosis signaling.

Dasari S, Samy ALPA, Kajdacsy-Balla A, Bosland MC, Munirathinam G.

Food Chem Toxicol. 2018 May;115:218-227. doi: 10.1016/j.fct.2018.02.018. Epub 2018 Feb 9.

14.

A Novel l-Asparaginase with low l-Glutaminase Coactivity Is Highly Efficacious against Both T- and B-cell Acute Lymphoblastic Leukemias In Vivo.

Nguyen HA, Su Y, Zhang JY, Antanasijevic A, Caffrey M, Schalk AM, Liu L, Rondelli D, Oh A, Mahmud DL, Bosland MC, Kajdacsy-Balla A, Peirs S, Lammens T, Mondelaers V, De Moerloose B, Goossens S, Schlicht MJ, Kabirov KK, Lyubimov AV, Merrill BJ, Saunthararajah Y, Van Vlierberghe P, Lavie A.

Cancer Res. 2018 Mar 15;78(6):1549-1560. doi: 10.1158/0008-5472.CAN-17-2106. Epub 2018 Jan 17.

15.

δ-Tocopherol inhibits the development of prostate adenocarcinoma in prostate specific Pten-/- mice.

Wang H, Yang X, Liu A, Wang G, Bosland MC, Yang CS.

Carcinogenesis. 2018 Feb 9;39(2):158-169. doi: 10.1093/carcin/bgx128.

16.

Vitamin K and its analogs: Potential avenues for prostate cancer management.

Dasari S, Ali SM, Zheng G, Chen A, Dontaraju VS, Bosland MC, Kajdacsy-Balla A, Munirathinam G.

Oncotarget. 2017 May 19;8(34):57782-57799. doi: 10.18632/oncotarget.17997. eCollection 2017 Aug 22. Review.

17.

Presence of Salmonella AvrA in colorectal tumor and its precursor lesions in mouse intestine and human specimens.

Lu R, Bosland M, Xia Y, Zhang YG, Kato I, Sun J.

Oncotarget. 2017 Jul 6;8(33):55104-55115. doi: 10.18632/oncotarget.19052. eCollection 2017 Aug 15.

18.

The common parasite Toxoplasma gondii induces prostatic inflammation and microglandular hyperplasia in a mouse model.

Colinot DL, Garbuz T, Bosland MC, Wang L, Rice SE, Sullivan WJ Jr, Arrizabalaga G, Jerde TJ.

Prostate. 2017 Jul;77(10):1066-1075. doi: 10.1002/pros.23362. Epub 2017 May 12.

19.

The Development of Prostate Adenocarcinoma in a Transgender Male to Female Patient: Could Estrogen Therapy Have Played a Role?

Sharif A, Malhotra NR, Acosta AM, Kajdacsy-Balla AA, Bosland M, Guzman G, Prins GS, Abern MR.

Prostate. 2017 Jun;77(8):824-828. doi: 10.1002/pros.23322. Epub 2017 Feb 13.

PMID:
28191651
20.

The anti-inflammatory effect of montelukast, a cysteinyl leukotriene receptor-1 antagonist, against estradiol-induced nonbacterial inflammation in the rat prostate.

Said MM, Bosland MC.

Naunyn Schmiedebergs Arch Pharmacol. 2017 Feb;390(2):197-205. doi: 10.1007/s00210-016-1325-4. Epub 2016 Dec 1.

PMID:
27909742
21.

Hepatoma-derived growth factor: A survival-related protein in prostate oncogenesis and a potential target for vitamin K2.

Shetty A, Dasari S, Banerjee S, Gheewala T, Zheng G, Chen A, Kajdacsy-Balla A, Bosland MC, Munirathinam G.

Urol Oncol. 2016 Nov;34(11):483.e1-483.e8. doi: 10.1016/j.urolonc.2016.05.027. Epub 2016 Sep 28.

22.

Carnosic acid promotes degradation of the androgen receptor and is regulated by the unfolded protein response pathway in vitro and in vivo.

Petiwala SM, Li G, Bosland MC, Lantvit DD, Petukhov PA, Johnson JJ.

Carcinogenesis. 2016 Aug;37(8):827-838. doi: 10.1093/carcin/bgw052. Epub 2016 Jun 7.

PMID:
27267997
23.

Is There a Future for Chemoprevention of Prostate Cancer?

Bosland MC.

Cancer Prev Res (Phila). 2016 Aug;9(8):642-7. doi: 10.1158/1940-6207.CAPR-16-0088. Epub 2016 Apr 20.

24.

Differences in the carcinogenic evaluation of glyphosate between the International Agency for Research on Cancer (IARC) and the European Food Safety Authority (EFSA).

Portier CJ, Armstrong BK, Baguley BC, Baur X, Belyaev I, Bellé R, Belpoggi F, Biggeri A, Bosland MC, Bruzzi P, Budnik LT, Bugge MD, Burns K, Calaf GM, Carpenter DO, Carpenter HM, López-Carrillo L, Clapp R, Cocco P, Consonni D, Comba P, Craft E, Dalvie MA, Davis D, Demers PA, De Roos AJ, DeWitt J, Forastiere F, Freedman JH, Fritschi L, Gaus C, Gohlke JM, Goldberg M, Greiser E, Hansen J, Hardell L, Hauptmann M, Huang W, Huff J, James MO, Jameson CW, Kortenkamp A, Kopp-Schneider A, Kromhout H, Larramendy ML, Landrigan PJ, Lash LH, Leszczynski D, Lynch CF, Magnani C, Mandrioli D, Martin FL, Merler E, Michelozzi P, Miligi L, Miller AB, Mirabelli D, Mirer FE, Naidoo S, Perry MJ, Petronio MG, Pirastu R, Portier RJ, Ramos KS, Robertson LW, Rodriguez T, Röösli M, Ross MK, Roy D, Rusyn I, Saldiva P, Sass J, Savolainen K, Scheepers PT, Sergi C, Silbergeld EK, Smith MT, Stewart BW, Sutton P, Tateo F, Terracini B, Thielmann HW, Thomas DB, Vainio H, Vena JE, Vineis P, Weiderpass E, Weisenburger DD, Woodruff TJ, Yorifuji T, Yu IJ, Zambon P, Zeeb H, Zhou SF.

J Epidemiol Community Health. 2016 Aug;70(8):741-5. doi: 10.1136/jech-2015-207005. Epub 2016 Mar 3. No abstract available.

25.

Interactive effects of 9-cis-retinoic acid and androgen on proliferation, differentiation, and apoptosis of LNCaP prostate cancer cells.

Eskra JN, Kuiper JW, Walden PD, Bosland MC, Özten N.

Eur J Cancer Prev. 2017 Jan;26(1):71-77.

PMID:
26886237
26.

Soy isoflavone exposure through all life stages accelerates 17β-estradiol-induced mammary tumor onset and growth, yet reduces tumor burden, in ACI rats.

Möller FJ, Pemp D, Soukup ST, Wende K, Zhang X, Zierau O, Muders MH, Bosland MC, Kulling SE, Lehmann L, Vollmer G.

Arch Toxicol. 2016 Aug;90(8):1907-16. doi: 10.1007/s00204-016-1674-2. Epub 2016 Feb 9.

PMID:
26861028
27.

Cancer chemoprevention research with selenium in the post-SELECT era: Promises and challenges.

Lü J, Zhang J, Jiang C, Deng Y, Özten N, Bosland MC.

Nutr Cancer. 2016;68(1):1-17. doi: 10.1080/01635581.2016.1105267. Epub 2015 Nov 23. Review.

28.

Dietary tocopherols inhibit PhIP-induced prostate carcinogenesis in CYP1A-humanized mice.

Chen JX, Li G, Wang H, Liu A, Lee MJ, Reuhl K, Suh N, Bosland MC, Yang CS.

Cancer Lett. 2016 Feb 1;371(1):71-8. doi: 10.1016/j.canlet.2015.11.010. Epub 2015 Nov 12.

29.

Methylseleninic Acid Superactivates p53-Senescence Cancer Progression Barrier in Prostate Lesions of Pten-Knockout Mouse.

Wang L, Guo X, Wang J, Jiang C, Bosland MC, Lü J, Deng Y.

Cancer Prev Res (Phila). 2016 Jan;9(1):35-42. doi: 10.1158/1940-6207.CAPR-15-0236. Epub 2015 Oct 28.

30.

A Perspective on Prostate Carcinogenesis and Chemoprevention.

Bosland MC, Ozten N, Eskra JN, Mahmoud AM.

Curr Pharmacol Rep. 2015 Aug 1;1(4):258-265. Epub 2015 Apr 11.

31.

How to Rationally Identify Promising Cancer Chemoprevention Agents?

Bosland MC.

J Natl Cancer Inst. 2015 Sep 29;107(12):djv288. doi: 10.1093/jnci/djv288. Print 2015 Dec. No abstract available.

PMID:
26420883
32.

Genistein increases estrogen receptor beta expression in prostate cancer via reducing its promoter methylation.

Mahmoud AM, Al-Alem U, Ali MM, Bosland MC.

J Steroid Biochem Mol Biol. 2015 Aug;152:62-75. doi: 10.1016/j.jsbmb.2015.04.018. Epub 2015 Apr 27.

33.

Flaxseed suppressed prostatic epithelial proliferation in a rat model of benign prostatic hyperplasia.

Said MM, Hassan NS, Schlicht MJ, Bosland MC.

J Toxicol Environ Health A. 2015;78(7):453-65. doi: 10.1080/15287394.2014.993779.

PMID:
25785559
34.

Phosphatidylinositol 3-kinase, class 2 beta (PI3KC2β) isoform contributes to neuroblastoma tumorigenesis.

Russo A, Okur MN, Bosland M, O'Bryan JP.

Cancer Lett. 2015 Apr 10;359(2):262-8. doi: 10.1016/j.canlet.2015.01.026. Epub 2015 Jan 23.

35.

Identification of secretaglobin Scgb2a1 as a target for developmental reprogramming by BPA in the rat prostate.

Wong RL, Wang Q, Treviño LS, Bosland MC, Chen J, Medvedovic M, Prins GS, Kannan K, Ho SM, Walker CL.

Epigenetics. 2015;10(2):127-34. doi: 10.1080/15592294.2015.1009768.

36.

Author's response to RE: Testosterone treatment is a potent tumor promoter for the rat prostate.

Bosland MC.

Endocrinology. 2015 Jan;156(1):L3-4. doi: 10.1210/en.2014-1911. No abstract available.

PMID:
25526554
37.

Testosterone treatment is a potent tumor promoter for the rat prostate.

Bosland MC.

Endocrinology. 2014 Dec;155(12):4629-33. doi: 10.1210/en.2014-1688. Epub 2014 Sep 23.

38.

L-selenomethionine does not protect against testosterone plus 17β-estradiol-induced oxidative stress and preneoplastic lesions in the prostate of NBL rats.

Özten N, Schlicht M, Diamond AM, Bosland MC.

Nutr Cancer. 2014;66(5):825-34. doi: 10.1080/01635581.2014.904907. Epub 2014 Apr 28.

39.

HMGB1 in hormone-related cancer: a potential therapeutic target.

Srinivasan M, Banerjee S, Palmer A, Zheng G, Chen A, Bosland MC, Kajdacsy-Balla A, Kalyanasundaram R, Munirathinam G.

Horm Cancer. 2014 Jun;5(3):127-39. doi: 10.1007/s12672-014-0175-0. Epub 2014 Apr 10. Review.

PMID:
24718937
40.

Soy isoflavones and prostate cancer: a review of molecular mechanisms.

Mahmoud AM, Yang W, Bosland MC.

J Steroid Biochem Mol Biol. 2014 Mar;140:116-32. doi: 10.1016/j.jsbmb.2013.12.010. Epub 2013 Dec 25. Review.

41.

Soy protein and recurrence of prostate cancer--reply.

Bosland MC, Kato I, Zeleniuch-Jacquotte A.

JAMA. 2013 Dec 4;310(21):2312-3. doi: 10.1001/jama.2013.278613. No abstract available.

PMID:
24302097
42.

Differential effects of genistein on prostate cancer cells depend on mutational status of the androgen receptor.

Mahmoud AM, Zhu T, Parray A, Siddique HR, Yang W, Saleem M, Bosland MC.

PLoS One. 2013 Oct 22;8(10):e78479. doi: 10.1371/journal.pone.0078479. eCollection 2013.

43.

L-Methionine inhibits growth of human pancreatic cancer cells.

Benavides MA, Bosland MC, da Silva CP, Gomes Sares CT, de Oliveira AM, Kemp R, dos Reis RB, Martins VR, Sampaio SV, Bland KI, Grizzle WE, dos Santos JS.

Anticancer Drugs. 2014 Feb;25(2):200-3. doi: 10.1097/CAD.0000000000000038.

44.

Vitamin k2, a naturally occurring menaquinone, exerts therapeutic effects on both hormone-dependent and hormone-independent prostate cancer cells.

Samykutty A, Shetty AV, Dakshinamoorthy G, Kalyanasundaram R, Zheng G, Chen A, Bosland MC, Kajdacsy-Balla A, Gnanasekar M.

Evid Based Complement Alternat Med. 2013;2013:287358. doi: 10.1155/2013/287358. Epub 2013 Aug 24.

45.

Effect of soy protein isolate supplementation on biochemical recurrence of prostate cancer after radical prostatectomy: a randomized trial.

Bosland MC, Kato I, Zeleniuch-Jacquotte A, Schmoll J, Enk Rueter E, Melamed J, Kong MX, Macias V, Kajdacsy-Balla A, Lumey LH, Xie H, Gao W, Walden P, Lepor H, Taneja SS, Randolph C, Schlicht MJ, Meserve-Watanabe H, Deaton RJ, Davies JA.

JAMA. 2013 Jul 10;310(2):170-8. doi: 10.1001/jama.2013.7842.

46.

HMGB1: A Promising Therapeutic Target for Prostate Cancer.

Gnanasekar M, Kalyanasundaram R, Zheng G, Chen A, Bosland MC, Kajdacsy-Balla A.

Prostate Cancer. 2013;2013:157103. doi: 10.1155/2013/157103. Epub 2013 May 12.

47.

Conditional inactivation of p53 in mouse ovarian surface epithelium does not alter MIS driven Smad2-dominant negative epithelium-lined inclusion cysts or teratomas.

Quartuccio SM, Lantvit DD, Bosland MC, Burdette JE.

PLoS One. 2013 May 31;8(5):e65067. doi: 10.1371/journal.pone.0065067. Print 2013.

48.

A perspective on the role of estrogen in hormone-induced prostate carcinogenesis.

Bosland MC.

Cancer Lett. 2013 Jun 28;334(1):28-33. doi: 10.1016/j.canlet.2012.08.027. Epub 2012 Aug 29. Review.

49.

Dietary carcinogen 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine-induced prostate carcinogenesis in CYP1A-humanized mice.

Li G, Wang H, Liu AB, Cheung C, Reuhl KR, Bosland MC, Yang CS.

Cancer Prev Res (Phila). 2012 Jul;5(7):963-72. doi: 10.1158/1940-6207.CAPR-12-0023. Epub 2012 May 11.

50.

Soy isoflavone supplementation for breast cancer risk reduction: a randomized phase II trial.

Khan SA, Chatterton RT, Michel N, Bryk M, Lee O, Ivancic D, Heinz R, Zalles CM, Helenowski IB, Jovanovic BD, Franke AA, Bosland MC, Wang J, Hansen NM, Bethke KP, Dew A, Coomes M, Bergan RC.

Cancer Prev Res (Phila). 2012 Feb;5(2):309-19. doi: 10.1158/1940-6207.CAPR-11-0251.

Supplemental Content

Loading ...
Support Center